rs75895925
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_018418.5(SPATA7):c.1183C>T(p.Arg395*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000149 in 1,609,924 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_018418.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151914Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000480 AC: 12AN: 250134Hom.: 0 AF XY: 0.0000592 AC XY: 8AN XY: 135248
GnomAD4 exome AF: 0.0000158 AC: 23AN: 1457892Hom.: 0 Cov.: 29 AF XY: 0.0000152 AC XY: 11AN XY: 725278
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152032Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74308
ClinVar
Submissions by phenotype
Leber congenital amaurosis 3 Pathogenic:3Other:1
- -
Variant is expected to truncate >30% of SPATA7 and causes LOF; LOF is a known disease mechanism for the protein (PVS1). Homozygous allele count in gnomAD exomes or genomes are less than 0 (PM2). -
- -
This sequence change creates a premature translational stop signal (p.Arg395*) in the SPATA7 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 205 amino acid(s) of the SPATA7 protein. This variant is present in population databases (rs75895925, gnomAD 0.02%). This premature translational stop signal has been observed in individuals with juvenile-onset retinitis pigmentosa (PMID: 19268277, 21602930). ClinVar contains an entry for this variant (Variation ID: 1397). This variant disrupts a region of the SPATA7 protein in which other variant(s) (p.Asn454Lysfs*2) have been determined to be pathogenic (internal data). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:2
Nonsense variant in the C-terminus predicted to result in protein truncation, as the last 205 amino acids are lost, and other loss-of-function variants have been reported downstream in the Human Gene Mutation Database (HGMD; ); This variant is associated with the following publications: (PMID: 20301475, 32799588, 27422788, 25525159, 19268277, 31908400, 32141364, 27375279, 25814828, 21310915, 21602930, 20104588, 31589614) -
- -
Retinal dystrophy Pathogenic:2
- -
- -
Retinitis pigmentosa 94, variable age at onset Pathogenic:1
- -
Leber congenital amaurosis Pathogenic:1
Variant summary: SPATA7 c.1183C>T (p.Arg395X) results in a premature termination codon, predicted to cause a truncation of the encoded protein, which is a commonly known mechanism for disease. The variant allele was found at a frequency of 4.8e-05 in 250134 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in SPATA7 causing Leber Congenital Amaurosis (4.8e-05 vs 0.00087), allowing no conclusion about variant significance. c.1183C>T has been reported either at a homozygous state or in trans along with a second pathogenic variant in at-least three individuals affected with early-onset ocular diseases including poor vision, ocular digital sign, fundus changes of attenuated vessels, tapetoretinal degeneration, retina degeneration, and/or extinguished ERG recording of rods and cones (example, Xiao_2019). These data indicate that the variant is likely to be associated with Leber Congenital Amaurosis. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 31908400). Three submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at